Safety,efficacy and functional outcomes of photoselective vaporisation of the prostate: A single-centre experience

Abstract

Objective:

The objective of this study was to report the safety, efficacy and functional outcomes following photoselective vaporisation of prostate (PVP) with GreenLight laser for benign prostatic enlargement (BPE).

Material and methods:

We retrospectively analysed men who underwent PVP from April 2011 to August 2019 for BPE. Preoperative, intraoperative and postoperative details were retrieved from electronic data software. The perioperative and functional outcomes were analysed.

Results:

A total of 147 patients, with a mean age of 65.4 years, underwent PVP (51 patients – high performance system (HPS), 120 Watts; 96 patients – xcelerated performance system (XPS), 180 Watts). In 20 (13.6%) patients, antiplatelet or anticoagulant were continued in the perioperative period. The mean operative time, lasing time, catheterization time and hospital stay were 54.4 minutes, 38.0 minutes, 48.7 hours and 2.73 days, respectively. Postoperatively, all the functional outcomes IPSS (international prostate symptom score), QOL (quality of life), Qmax (maximum flow rate) and PVR (postvoid residue) were significantly improved from the baseline. The most common complication was dysuria (36.7%). There was no significant perioperative bleeding complications in high-risk men who were on antiplatelet or anticoagulant therapy.

Conclusion:

PVP is a safe, efficacious and durable surgical option in BPE including patients on antiplatelet or anticoagulant therapy.

Level of evidence:

Level 4

Keywords

Benign prostatic enlargement GreenLight laser laser prostatectomy vaporisation functional outcomes

Get full access to this article

View all access options for this article.

References

Ajib

Mansour

Zanaty

, et al. Photoselective vaporization of the prostate with the 180-W XPSGreenlight laser: Five-year experience of safety, efficiency, and functional outcomes. Can Urol Assoc J 2018; 12(7): E318–E324.

Sandhu

Leong

Das

. Photoselective vaporization of the prostate: Application, outcomes and safety. Can J Urol 2019; 26(4, Suppl. 1): 8–12.

Park

Cho

, et al. 5-year long-term efficacy of 120-W GreenLight photoselective vaporization of the prostate for benign prostate hyperplasia. PLOS ONE 2017; 12(9): e0184442.

Chen

C-H

Chiang

P-H

. GreenLight 180-W XPS laser versus 120-W HPS laser for the treatment of benign prostate hyperplasia by a single experienced urologist. Urol Sci 2016; 27: 234–237.

Benign Prostatic Hyperplasia (BPH) Guideline. American Urological Association, https://www.auanet.org/guidelines/benign-prostatic-hyperplasia-(bph)-guideline (accessed 5 June 2020).

Muir

Gómez Sancha

Bachmann

, et al. Techniques and training with greenlight HPS 120-W laser therapy of the prostate: Position paper. Europ Urol Suppl 2008; 7: 370–377.

Zorn

Liberman

. GreenLight 180W XPS photovaporization of the prostate: How I do it. Can J Urol 2011; 18: 5918–5926.

Dindo

Demartines

Clavien

P-A

. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240(2): 205–213.

Gravas

Cornu

Gacci

, et al. EAU guidelines on management of non-neurogenic male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO) 2020. In: European Association of Urology guidelines. 2020 edition. Arnhem: European Association of Urology Guidelines Office, 2020, http://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/

10.

Brunken

Seitz

Woo

. A systematic review of experience of 180-W XPS GreenLight laser vaporisation of the prostate in 1640 men. BJU Int 2015; 116(4): 531–537.

11.

Ruszat

Wyler

Seitz

, et al. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: Update of a prospective non-randomized two-centre study. BJU Int 2008; 102(10): 1432–1438; discussion 1438–1439.

12.

Horasanli

Silay

Altay

, et al. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: A short-term prospective randomized trial. Urology 2008; 71: 247–251.

13.

Kang

Jebens

Malek

, et al. Laser vaporization of bovine prostate: A quantitative comparison of potassium-titanyl-phosphate and lithium triborate lasers. J Urol 2008; 180(6): 2675–2680.

14.

Al-Ansari

Younes

Sampige

, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: A randomized clinical trial with midterm follow-up. Eur Urol 2010; 58(3): 349–355.

15.

Bachmann

Tubaro

Barber

, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol 2015; 193(2): 570–578.

16.

Thomas

Tubaro

Barber

, et al. A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: Two-yr outcomes of the GOLIATH study. Eur Urol 2016; 69(1): 94–102.

17.

Ben-Zvi

Hueber

P-A

Liberman

, et al. GreenLight XPS 180W vs HPS 120W laser therapy for benign prostate hyperplasia: A prospective comparative analysis after 200 cases in a single-center study. Urology 2013; 81: 853–858.

18.

Altay

Erkurt

Kiremit

, et al. 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci 2015; 30(1): 317–323.

19.

Ruszat

Seitz

Wyler

, et al. GreenLight laser vaporization of the prostate: Single-center experience and long-term results after 500 procedures. Eur Urol 2008; 54: 893–901.

20.

Hai

. Photoselective vaporization of prostate: Five-year outcomes of entire clinic patient population. Urology 2009; 73(4): 807–810.

21.

Calves

Thoulouzan

Perrouin-Verbe

M-A

, et al. Long-term patient-reported clinical outcomes and reoperation rate after photovaporization with the XPS-180W GreenLight Laser. Eur Urol Focus 2019; 5(4): 676–680.

22.

Ruszat

Wyler

Forster

, et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007; 51(4): 1031–1038; discussion 1038–1041.

23.

Sandhu

Gonzalez

, et al. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005; 19(10): 1196–1198.

24.

Sandhu

Leong

Das

. Photoselective vaporization of the prostate: Application, outcomes and safety. Can J Urol 2019; 26(4 Suppl. 1): 8–12.

25.

Lai

Peng

Diao

, et al. Comparison of photoselective green light laser vaporisation versus traditional transurethral resection for benign prostate hyperplasia: An updated systematic review and meta-analysis of randomised controlled trials and prospective studies. BMJ Open 2019; 219(8): e028855.